Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose

BACKGROUND/AIMS: Sofosbuvir (SOF)-based therapy has been used in Korean patients with chronic hepatitis C virus (HCV) infection since January 2016. This study aimed to investigate the real-life effectiveness and safety of SOF-based therapy in genotype 2 HCV infection. METHODS: From January to Decemb...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Gut Liver
Prif Awduron: Jang, Eun Sun, Kim, Kyung-Ah, Kim, Young Seok, Kim, In Hee, Lee, Byung Seok, Lee, Youn Jae, Chung, Woo Jin, Jeong, Sook-Hyang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Editorial Office of Gut and Liver 2020
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7667937/
https://ncbi.nlm.nih.gov/pubmed/32000468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19260
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg